Welcome to our dedicated page for Privia Health Group news (Ticker: PRVA), a resource for investors and traders seeking the latest updates and insights on Privia Health Group stock.
Privia Health Group, Inc. (symbol: PRVA) is a leading technology-driven national physician enablement company. The organization collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering high-value care both in-person and through virtual platforms. Privia Health focuses on transforming healthcare from a 'sick care' model to a 'well care' model by using innovative technologies and scalable operations.
The company's recent achievements include a significant partnership with Navina, an AI-powered primary care platform. This collaboration aims to equip Privia Health's extensive network of over 3,800 providers and more than 1,000 practice locations by integrating advanced AI technology to improve workflows, patient care, and value-based initiatives. With the help of Navina's clinical intelligence, physicians can better assess patients' health, make informed clinical decisions, and reduce administrative burdens.
Privia Health is recognized for its end-to-end, cloud-based technology platform that reduces unnecessary healthcare costs and achieves better outcomes for patients and providers. The platform is led by top industry talent and exceptional physician leadership, ensuring high-quality healthcare experiences. The company's financial condition remains strong, with net cash provided by operating activities significantly increased to $80.8 million in 2023, a 71.2% rise from the previous year.
The company's culture is defined by passion, curiosity, and a commitment to making a tangible difference in healthcare. Privia Health looks for individuals who are resourceful, hardworking, and driven to challenge the status quo. This ethos is reflected in the company's comprehensive approach to healthcare, striving to create positive, long-lasting impacts on the communities it serves.
For more information, visit priviahealth.com.
Privia Health Group, Inc. (Nasdaq: PRVA) has launched three new Accountable Care Organizations (ACOs) in Maryland, Florida, and Tennessee, bringing the total to seven ACOs in its portfolio. Effective January 1, 2022, the Privia Quality Network now includes over 1,900 independent providers serving 168,000+ Medicare beneficiaries. Four ACOs have transitioned to the MSSP Enhanced Track, which entails significant financial risks. In 2020, Privia achieved $86.5 million in shared savings through MSSP, with total savings exceeding $576 million since 2014.
Privia Health Group, Inc. (Nasdaq: PRVA) has appointed Jeffrey S. Sherman as Executive Vice President and Chief Financial Officer, effective immediately. Sherman, who brings significant financial and healthcare experience from previous roles, will oversee finance and accounting activities. Privia Health CEO Shawn Morris emphasized that Sherman’s background will support the company’s growth and long-term value creation. Sherman succeeds David Mountcastle, who is leaving the company after a successful tenure. Privia Health focuses on optimizing physician practices and enhancing patient experiences.
Privia Health Group, Inc. (Nasdaq: PRVA) has announced new capitated arrangements with HealthFirst Health Plan and Humana for its Accountable Care Organizations (ACOs) in Florida and the Mid-Atlantic region. Effective January 1, 2022, these agreements will provide healthcare services to approximately 23,000 Medicare Advantage beneficiaries. The company expects to generate $230 million in practice collections and GAAP revenue from these contracts in 2022, marking a shift from fee-for-service to care management fees for enhanced healthcare services.
ARLINGTON, Va., Jan. 04, 2022 – Privia Health Group, Inc. (Nasdaq: PRVA) will participate in the 40th Annual J.P. Morgan Healthcare Conference. The management team is scheduled to present a business overview during a virtual fireside chat on January 10, 2022, at 3:00 PM ET. A webcast, replay, and accompanying slide presentation will be available on their investor relations website.
Privia Health is a technology-driven physician enablement company that collaborates with medical groups and health systems to optimize practices, improve patient experiences, and enhance healthcare quality.
Privia Health Group, Inc. (Nasdaq: PRVA) has priced its public offering of 6,000,000 shares of common stock at $29.00 per share. The offering, initiated by selling stockholders, includes a 30-day option for underwriters to purchase an additional 900,000 shares. The company will not receive any proceeds from this secondary offering, which is set to close on November 23, 2021. The offering is managed by leading financial institutions including Goldman Sachs and J.P. Morgan. Forward-looking statements highlight potential uncertainties regarding the completion of the offering.
Privia Health Group, Inc. (Nasdaq: PRVA) announced a public offering of 6,000,000 shares of common stock by certain selling stockholders, with a 30-day option for underwriters to purchase an additional 900,000 shares. The company will not receive any proceeds from this offering, as costs will be borne by the selling stockholders. Goldman Sachs & Co. LLC and J.P. Morgan are leading the offering. A registration statement has been filed but is not yet effective, and the offering is subject to numerous conditions outside Privia's control.
Privia Health Group, Inc. (PRVA) announced robust third-quarter results with total revenue reaching $251.5 million, a 21.4% increase year-over-year. However, the company reported a net loss of $9.1 million, or $0.09 per share, compared to a profit of $16.7 million in the same period last year. Practice collections rose to $401.5 million, and adjusted EBITDA grew by 51.9% to $13.9 million. The firm entered the California and West Texas markets, raising its full-year 2021 guidance across multiple metrics, signaling strong growth potential ahead.
Privia Health Group, Inc. (Nasdaq: PRVA), a national physician enablement company, announced its participation in three key investor conferences. The events are scheduled for November 10 at the Credit Suisse Healthcare Conference, November 18 at the Canaccord Genuity Digital Health & Services Forum, and December 1 at the Piper Sandler Healthcare Conference. Webcasts and slide presentations will be accessible via the company's investor relations website. Privia Health focuses on enhancing physician practices and patient experiences through advanced technology.
Privia Health Group, Inc. (PRVA) is expanding its national provider network by collaborating with over 430 new providers in California and Texas. This includes partnerships with BASS Medical Group in California and Abilene Diagnostic Clinic in West Texas. These ventures aim to enhance patient care and support healthcare providers in their transition to value-based care. The company plans to update its full-year 2021 guidance following its third-quarter financial results on November 8, reflecting the anticipated impact of these expansions.
Privia Health Group (Nasdaq: PRVA) is set to announce its third-quarter financial results for the period ending September 30, 2021, before market open on November 8, 2021. The financial press release will be available at ir.priviahealth.com by 7:00 am ET. Management will also hold a conference call at 8:00 am ET to discuss the results and future outlook. Interested parties can participate via a webcast or by dialing 855-940-5315.
FAQ
What is the current stock price of Privia Health Group (PRVA)?
What is the market cap of Privia Health Group (PRVA)?
What is Privia Health Group, Inc.?
What recent partnership has Privia Health announced?
How many providers are part of Privia Health's network?
What is the financial performance of Privia Health in 2023?
What is the core business model of Privia Health?
What type of care does Privia Health provide?
What makes Privia Health's technology platform unique?
What are the company's core values?
How does Privia Health reward doctors?